$234 Million is the total value of KNOTT DAVID M's 166 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AGACU | New | African Gold Acquistion Corp. | $6,106,000 | – | 618,000 | +100.0% | 2.61% | – |
| TWLVU | New | Twelve Seas Investment Company II | $5,073,000 | – | 515,000 | +100.0% | 2.17% | – |
| GLHAU | New | Glass Houses Acquisition Corp. | $5,015,000 | – | 500,000 | +100.0% | 2.14% | – |
| LOKMU | New | Live Oak Mobility Aquisition Corp. | $3,594,000 | – | 360,152 | +100.0% | 1.54% | – |
| KAIR | New | Kairos Acquisition Corp. | $2,546,000 | – | 261,374 | +100.0% | 1.09% | – |
| CAP | New | Capitol Investment Corp. V | $2,525,000 | – | 250,000 | +100.0% | 1.08% | – |
| UTHR | New | United Therapeutics Corporation | $2,425,000 | – | 14,500 | +100.0% | 1.04% | – |
| MSACU | New | Medicus Science Acquisition, Corp. | $1,970,000 | – | 200,000 | +100.0% | 0.84% | – |
| TMKR | New | Tastemaker Acquisition Corp. | $1,948,000 | – | 200,000 | +100.0% | 0.83% | – |
| BRPMU | New | B. Riley Principal 150 Merger Corp. | $1,760,000 | – | 175,963 | +100.0% | 0.75% | – |
| KAIRW | New | Kairos Acquisition Corp. Warrants | $1,503,000 | – | 130,687 | +100.0% | 0.64% | – |
| ASLN | New | ASLAN Pharmaceuticals Limited | $1,465,000 | – | 437,412 | +100.0% | 0.63% | – |
| TMKRW | New | Tastemaker Acquisition Corp. Warrants | $1,150,000 | – | 100,000 | +100.0% | 0.49% | – |
| ROCRU | New | Roth CH Acquisition III Co. | $1,000,000 | – | 100,000 | +100.0% | 0.43% | – |
| CAPWS | New | Capitol Investment Corp. V Warrants | $958,000 | – | 83,333 | +100.0% | 0.41% | – |
| LGVU | New | Longview Acquisition Corp II | $642,000 | – | 63,900 | +100.0% | 0.28% | – |
| IMVT | New | Immunovant Inc. | $547,000 | – | 34,100 | +100.0% | 0.23% | – |
| XBI | New | SPDR S&P Biotech ETF | $515,000 | – | 3,800 | +100.0% | 0.22% | – |
| FLL | New | Full House Resort Inc. | $426,000 | – | 50,000 | +100.0% | 0.18% | – |
| SEEL | New | Seelos Therapeutics, Inc. | $361,000 | – | 72,367 | +100.0% | 0.15% | – |
| IBERU | New | Ibere Pharmaceuticals | $355,000 | – | 36,000 | +100.0% | 0.15% | – |
| BFLY | New | Butterfly Network, Inc. | $309,000 | – | 18,380 | +100.0% | 0.13% | – |
| FB | New | Facebook Inc. | $292,000 | – | 990 | +100.0% | 0.12% | – |
| PSTX | New | Poseida Therapeutics, Inc. | $282,000 | – | 29,566 | +100.0% | 0.12% | – |
| WARRU | New | Warrior Technologies Acquisition Company | $248,000 | – | 25,000 | +100.0% | 0.11% | – |
| TIGR | New | Up Fintech Holdings | $244,000 | – | 13,736 | +100.0% | 0.10% | – |
| New | ALX Oncology Holdings Inc | $236,000 | – | 3,200 | +100.0% | 0.10% | – | |
| JMIA | New | Jumia Technologies AG | $202,000 | – | 5,700 | +100.0% | 0.09% | – |
| SIOX | New | Sio Gene Therapies, Inc. | $183,000 | – | 70,000 | +100.0% | 0.08% | – |
| MLND | New | Millendo Therapeutics, Inc. | $165,000 | – | 137,900 | +100.0% | 0.07% | – |
| KAIRU | New | Kairos Acquisition Corp Units | $145,000 | – | 14,500 | +100.0% | 0.06% | – |
| CRIS | New | Curis, Inc. | $113,000 | – | 10,000 | +100.0% | 0.05% | – |
| MRK | New | Merck & Co. Inc. | $101,000 | – | 1,300 | +100.0% | 0.04% | – |
| ACQRU | New | Independence Holdings Corp Units | $95,000 | – | 9,500 | +100.0% | 0.04% | – |
| TMUS | New | T-Mobil US Inc. | $88,000 | – | 700 | +100.0% | 0.04% | – |
| SAIL | New | Sailpoint Technologies | $86,000 | – | 1,700 | +100.0% | 0.04% | – |
| GLPG | New | Galapagos NV | $77,000 | – | 1,000 | +100.0% | 0.03% | – |
| PRTS | New | Carparts.com Inc. | $53,000 | – | 3,700 | +100.0% | 0.02% | – |
| BCAC | New | Brookline Capital Acquisition Corp. | $39,000 | – | 4,000 | +100.0% | 0.02% | – |
| HCAQ | New | HealthCor Catalio Acquisition Corp. | $40,000 | – | 4,000 | +100.0% | 0.02% | – |
| BCACW | New | Brookline Capital Acq Corp. Warrants | $23,000 | – | 2,000 | +100.0% | 0.01% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Ligand Pharmaceuticals Incorporated | 34 | Q3 2021 | 52.6% |
| Pfizer Inc. | 34 | Q3 2021 | 17.4% |
| Capitol Federal S&L | 34 | Q3 2021 | 5.7% |
| JP Morgan Chase& Co. | 34 | Q3 2021 | 1.3% |
| Apple Inc. | 34 | Q3 2021 | 2.1% |
| Microsoft Corporation | 34 | Q3 2021 | 2.3% |
| AllianceBernstein Holdings PL Unit Ltd. | 34 | Q3 2021 | 0.9% |
| Johnson & Johnson | 34 | Q3 2021 | 0.6% |
| Mondelez Int'lt Inc. | 34 | Q3 2021 | 0.5% |
| Ryman Hospitality PPTYS Inc. | 34 | Q3 2021 | 0.4% |
View KNOTT DAVID M's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| LIGAND PHARMACEUTICALS INC | February 13, 2018 | 865,500 | 4.1% |
| Rand Logistics, Inc. | November 15, 2017 | 1,432,660 | 7.2% |
| Essex Rental Corp. | August 16, 2013 | 1,124,472 | 4.5% |
| Westway Group, Inc. | February 01, 2013 | ? | ? |
| FutureFuel Corp. | February 01, 2012 | 1,838,000 | 4.5% |
| COLUMBIA LABORATORIES INC | January 31, 2012 | ? | ? |
| Essex Rental Corp. | February 16, 2011 | 2,805,666 | 13.0% |
| Pet DRx CORPSold out | February 09, 2011 | 0 | 0.0% |
| China Ceramics Co., Ltd | October 14, 2010 | 1,350,000 | 10.3% |
| NABI BIOPHARMACEUTICALS | June 22, 2010 | 2,344,597 | 4.8% |
View KNOTT DAVID M's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2021-11-12 |
| 13F-HR | 2021-08-13 |
| 13F-HR | 2021-05-13 |
| 13F-HR | 2021-02-12 |
| 13F-HR | 2020-11-13 |
| 13F-HR | 2020-08-12 |
| 13F-HR | 2020-05-13 |
| 13F-HR | 2020-02-14 |
| 13F-HR | 2019-11-12 |
| 13F-HR | 2019-08-12 |
View KNOTT DAVID M's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.